MAJ'ARTHRO
Food supplement declared in France, declaration No 2023-12-544
MAJ'ARTHRO (MAJELIS) is a food supplement declared in France. Status: retrait du marché annoncé pour le 31 August 2027. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- MAJELIS
- Food business operator placing the product on the market
- SAS MAJELIS
- Status
- Retrait du marché annoncé pour le 31 August 2027
- Form
- Gélule
- Daily dose
- 2 à 4 gélules par jour
- Directions for use
- 2 à 4 gélules par jour avec un grand verre d'eau, en 2 prises au cours des repas.
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, À prendre en dehors des repas, Femmes enceintes, Insuffisance rénale, Problèmes cardiaques, Ulcère (estomac ou duodenum)
- Objectives stated by the manufacturer (these are not authorised claims)
- Articulations
Declaration 137482, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 31 August 2027, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Harpagophytum procumbens | Racine | Extrait sec aqueux | 700 mg |
| Ribes nigrum L. | Feuille | Extrait sec aqueux | 500 mg |
| Equisetum arvense L. | Parties aériennes | Poudre (de plantes séchées ou broyées) | 120 mg |
Additives
E470b, E464
Other ingredients
maltodextrine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas consommer en cas d’insuffisance cardiaque ou rénale œdémateuses, d’ulcère gastro-duodénal ou de calculs biliaires.Déconseillé aux femmes enceintes ou allaitantes.Réservé à l’adulte.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- MAJ'ARTHRO MAJELIS, declared in 2025 : different composition: 2 ingredient(s) added, 2 missing
- MAJ'ARTHRO MAJELIS, withdrawn from the market : different composition: 2 ingredient(s) added, 2 missing
Brand : MAJELIS